FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Johnson

Research Profile

Disorders

Living Beings

Concepts & Ideas

Anatomy

Physiology

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Susan K Keay; Samantha Leitzell; Ashley Ochrzcin; Min Zhan; George Clements; David E Johnson
A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study.
Senthilkumar Palaniyandi; Xiaoping Zhu; Christopher D Herren; David E Johnson; C Virginia Lockatell; Arindam Mitra; Suman Mukhopadhyay
BarA-UvrY two-component system regulates virulence of uropathogenic E. coli CFT073.
Biao Ma; Shih-Jung Pan; Renee Domergue; Tracey Rigby; Malcolm Whiteway; David E Johnson; Brendan P Cormack
High-affinity transporters for NAD+ precursors in Candida glabrata are regulated by Hst1 and induced in response to niacin limitation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Johnson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Susan K Keay; Samantha Leitzell; Ashley Ochrzcin; Min Zhan; George Clements; David E Johnson
A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study.
BMC urology 2012;12():17.
2012: Senthilkumar Palaniyandi; Xiaoping Zhu; Christopher D Herren; David E Johnson; C Virginia Lockatell; Arindam Mitra; Suman Mukhopadhyay
BarA-UvrY two-component system regulates virulence of uropathogenic E. coli CFT073.
PloS one 2012;7(2):e31348.
2009: Biao Ma; Shih-Jung Pan; Renee Domergue; Tracey Rigby; Malcolm Whiteway; David E Johnson; Brendan P Cormack
High-affinity transporters for NAD+ precursors in Candida glabrata are regulated by Hst1 and induced in response to niacin limitation.
Molecular and cellular biology 2009;29(15):4067-79.
2009: Eric L Buckles; Xiaolin Wang; M Chelsea Lane; C Virginia Lockatell; David E Johnson; David Rasko; harry mobley; Michael S Donnenberg
Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance.
The Journal of infectious diseases 2009;199(11):1689-97.
2008: Stephanie D Himpsl; C Virginia Lockatell; J Richard Hebel; David E Johnson; harry mobley
Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis.
Journal of medical microbiology 2008;57(Pt 9):1068-78.
2006: Jennifer A Snyder; Amanda L Lloyd; C Virginia Lockatell; David E Johnson; harry mobley
Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection.
Infection and immunity 2006;74(2):1387-93.
2006: Eric L Buckles; Xiaolin Wang; C Virginia Lockatell; David E Johnson; Michael S Donnenberg
PhoU enhances the ability of extraintestinal pathogenic Escherichia coli strain CFT073 to colonize the murine urinary tract.
Microbiology (Reading, England) 2006;152(Pt 1):153-60.
2005: M Chelsea Lane; Virginia Lockatell; Greta Monterosso; Daniel Lamphier; Julia Weinert; J Richard Hebel; David E Johnson; harry mobley
Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract.
Infection and immunity 2005;73(11):7644-56.
2005: Jennifer A Snyder; Brian Haugen; C Virginia Lockatell; Nathalie M Maroncle; Erin C Hagan; David E Johnson; Rodney A Welch; harry mobley
Coordinate expression of fimbriae in uropathogenic Escherichia coli.
Infection and immunity 2005;73(11):7588-96.
2005: Renee Domergue; Irene Castaño; Alejandro De Las Peñas; Margaret L Zupancic; Virginia Lockatell; J Richard Hebel; David E Johnson; Brendan P Cormack
Nicotinic acid limitation regulates silencing of Candida adhesins during UTI.
Science (New York, N.Y.) 2005;308(5723):866-70.
2004: Xin Li; Jarrod L Erbe; C Virginia Lockatell; David E Johnson; Michael G Jobling; Randall K Holmes; harry mobley
Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis.
Infection and immunity 2004;72(12):7306-10.
2004: Angela M Jansen; Virginia Lockatell; David E Johnson; harry mobley
Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation.
Infection and immunity 2004;72(12):7294-305.
2004: Jennifer A Snyder; Brian Haugen; Eric L Buckles; C Virginia Lockatell; David E Johnson; Michael S Donnenberg; Rodney A Welch; harry mobley
Transcriptome of uropathogenic Escherichia coli during urinary tract infection.
Infection and immunity 2004;72(11):6373-81.
2004: Eric L Buckles; Farah K Bahrani-Mougeot; Anita Molina; C Virginia Lockatell; David E Johnson; Cinthia Drachenberg; Valerie Burland; Frederick R Blattner; Michael S Donnenberg
Identification and characterization of a novel uropathogenic Escherichia coli-associated fimbrial gene cluster.
Infection and immunity 2004;72(7):3890-901.
2004: Laurel S Burall; Janette M Harro; Xin Li; C Virginia Lockatell; Stephanie D Himpsl; J Richard Hebel; David E Johnson; harry mobley
Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold.
Infection and immunity 2004;72(5):2922-38.
2004: Susan R Heimer; David Rasko; C Virginia Lockatell; David E Johnson; harry mobley
Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection.
Infection and immunity 2004;72(1):593-7.
2004: Xin Li; C Virginia Lockatell; David E Johnson; M Chelsea Lane; John W Warren; harry mobley
Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.
Infection and immunity 2004;72(1):66-75.
2003: Mare Cudic; C Virginia Lockatell; David E Johnson; Laszlo Otvos
In vitro and in vivo activity of an antibacterial peptide analog against uropathogens.
Peptides 2003;24(6):807-20.
2003: Angela M Jansen; C Virginia Lockatell; David E Johnson; harry mobley
Visualization of Proteus mirabilis morphotypes in the urinary tract: the elongated swarmer cell is rarely observed in ascending urinary tract infection.
Infection and immunity 2003;71(6):3607-13.
2003: Jonathan D Dattelbaum; C Virginia Lockatell; David E Johnson; harry mobley
UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections.
Infection and immunity 2003;71(2):1026-30.
2002: Farah K Bahrani-Mougeot; Eric L Buckles; C Virginia Lockatell; J Richard Hebel; David E Johnson; C M Tang; Michael S Donnenberg
Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract.
Molecular microbiology 2002;45(4):1079-93.
2002: Xin Li; C Virginia Lockatell; David E Johnson; harry mobley
Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis.
Molecular microbiology 2002;45(3):865-74.
2002: Nereus W Gunther; Jennifer A Snyder; Virginia Lockatell; Ian Blomfield; David E Johnson; harry mobley
Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off.
Infection and immunity 2002;70(7):3344-54.
2002: Rachel Schneider; C Virginia Lockatell; David E Johnson; Robert Belas
Detection and mutation of a luxS-encoded autoinducer in Proteus mirabilis.
Microbiology (Reading, England) 2002;148(Pt 3):773-82.
2002: Xin Li; Hui Zhao; C Virginia Lockatell; Cinthia Drachenberg; David E Johnson; harry mobley
Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection.
Infection and immunity 2002;70(1):389-94.
2001: Xin Li; David Rasko; C Virginia Lockatell; David E Johnson; harry mobley
Repression of bacterial motility by a novel fimbrial gene product.
The EMBO journal 2001;20(17):4854-62.
2001: Nathan Shankar; C Virginia Lockatell; Arto S Baghdayan; Cinthia Drachenberg; Michael S Gilmore; David E Johnson
Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection.
Infection and immunity 2001;69(7):4366-72.
2001: NW Gunther; Virginia Lockatell; David E Johnson; harry mobley
In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection.
Infection and immunity 2001;69(5):2838-46.
2000: David E Johnson; Cinthia Drachenberg; C Virginia Lockatell; MD Island; John W Warren; Michael S Donnenberg
The role of cytotoxic necrotizing factor-1 in colonization and tissue injury in a murine model of urinary tract infection.
FEMS immunology and medical microbiology 2000;28(1):37-41.
1999: David E Johnson; F K Bahrani; C Virginia Lockatell; Cinthia Drachenberg; J Richard Hebel; Robert Belas; John W Warren; harry mobley
Serum immunoglobulin response and protection from homologous challenge by Proteus mirabilis in a mouse model of ascending urinary tract infection.
Infection and immunity 1999;67(12):6683-7.
1999: Xin Li; David E Johnson; harry mobley
Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis.
Infection and immunity 1999;67(6):2822-33.
1999: Kimberly E Walker; S Moghaddame-Jafari; C Virginia Lockatell; David E Johnson; Robert Belas
ZapA, the IgA-degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells.
Molecular microbiology 1999;32(4):825-36.
1999: Hui Zhao; Xin Li; David E Johnson; harry mobley
Identification of protease and rpoN-associated genes of uropathogenic Proteus mirabilis by negative selection in a mouse model of ascending urinary tract infection.
Microbiology (Reading, England) 1999;145 ( Pt 1)():185-95.
1998: J K Lim; NW Gunther; Hui Zhao; David E Johnson; Susan K Keay; harry mobley
In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection.
Infection and immunity 1998;66(7):3303-10.
1998: David E Johnson; C Virginia Lockatell; R G Russell; J Richard Hebel; MD Island; A Stapleton; Walter E Stamm; John W Warren
Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice.
Infection and immunity 1998;66(7):3059-65.
1998: Hui Zhao; Richard B Thompson; Virginia Lockatell; David E Johnson; harry mobley
Use of green fluorescent protein to assess urease gene expression by uropathogenic Proteus mirabilis during experimental ascending urinary tract infection.
Infection and immunity 1998;66(1):330-5.
1997: Xin Li; Hui Zhao; L Geymonat; F Bahrani; David E Johnson; harry mobley
Proteus mirabilis mannose-resistant, Proteus-like fimbriae: MrpG is located at the fimbrial tip and is required for fimbrial assembly.
Infection and immunity 1997;65(4):1327-34.
1997: Hui Zhao; Xin Li; David E Johnson; I Blomfield; harry mobley
In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract.
Molecular microbiology 1997;23(5):1009-19.
1996: harry mobley; Robert Belas; V Lockatell; G Chippendale; Anna Trifillis; David E Johnson; John W Warren
Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection.
Infection and immunity 1996;64(12):5332-40.
1994: F K Bahrani; G Massad; C Virginia Lockatell; David E Johnson; R G Russell; John W Warren; harry mobley
Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection.
Infection and immunity 1994;62(8):3363-71.
1994: G Massad; C Virginia Lockatell; David E Johnson; harry mobley
Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection.
Infection and immunity 1994;62(2):536-42.
1993: harry mobley; Karen G Jarvis; J P Elwood; D I Whittle; C Virginia Lockatell; R G Russell; David E Johnson; Michael S Donnenberg; John W Warren
Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain.
Molecular microbiology 1993;10(1):143-55.
1993: David E Johnson; R G Russell; C Virginia Lockatell; J C Zulty; John W Warren
Urethral obstruction of 6 hours or less causes bacteriuria, bacteremia, and pyelonephritis in mice challenged with "nonuropathogenic" Escherichia coli.
Infection and immunity 1993;61(8):3422-8.
1993: David E Johnson; R G Russell; C Virginia Lockatell; J C Zulty; John W Warren; harry mobley
Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.
Infection and immunity 1993;61(7):2748-54.
1993: George L Drusano; David E Johnson; M Rosen; HC Standiford
Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis.
Antimicrobial agents and chemotherapy 1993;37(3):483-90.
1991: F K Bahrani; David E Johnson; D Robbins; harry mobley
Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection.
Infection and immunity 1991;59(10):3574-80.
1991: David E Johnson; C Virginia Lockatell; M Hall-Craggs; John W Warren
Mouse models of short- and long-term foreign body in the urinary bladder: analogies to the bladder segment of urinary catheters.
Laboratory animal science 1991;41(5):451-5.
1991: A L Soriano; R G Russell; David E Johnson; R Lagos; I Sechter; J Glenn Morris
Pathophysiology of Citrobacter diversus neonatal meningitis: comparative studies in an infant mouse model.
Infection and immunity 1991;59(4):1352-8.
1990: David E Johnson; H L Muncie; J L O'Reilly; John W Warren
An external urine collection device for incontinent women. Evaluation of long-term use.
Journal of the American Geriatrics Society 1990;38(9):1016-22.
1990: harry mobley; D M Green; Anna Trifillis; David E Johnson; G R Chippendale; C Virginia Lockatell; B D Jones; John W Warren
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.
Infection and immunity 1990;58(5):1281-9.
1990: B D Jones; C Virginia Lockatell; David E Johnson; John W Warren; harry mobley
Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection.
Infection and immunity 1990;58(4):1120-3.
1989: David E Johnson; J L O'Reilly; John W Warren
Clinical evaluation of an external urine collection device for nonambulatory incontinent women.
The Journal of urology 1989;141(3):535-7.
1987: David E Johnson; C Virginia Lockatell; M Hall-Craigs; harry mobley; John W Warren
Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients.
The Journal of urology 1987;138(3):632-5.
1985: David E Johnson; B Thompson; Frank M Calia
Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats.
Antimicrobial agents and chemotherapy 1985;28(6):735-9.
1985: J C Wade; HC Standiford; George L Drusano; David E Johnson; M R Moody; C I Bustamante; J H Joshi; C deJongh; Stephen C Schimpff
Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer.
The American journal of medicine 1985;78(6A):62-72.
1985: David E Johnson
Use of discriminative models of Pseudomonas aeruginosa bacteremia in granulocytopenic rats for testing antimicrobial efficacy.
European journal of clinical microbiology 1985;4(2):207-12.
1984: David E Johnson; L Weinberg; J Ciarkowski; P West; Rita R Colwell
Wound infection caused by Kanagawa-negative Vibrio parahaemolyticus.
Journal of clinical microbiology 1984;20(4):811-2.
1984: David E Johnson; Frank M Calia; D M Musher; A Goree
Resistance of Vibrio vulnificus to serum bactericidal and opsonizing factors: relation to virulence in suckling mice and humans.
The Journal of infectious diseases 1984;150(3):413-8.
1984: HC Standiford; David E Johnson; Stephen C Schimpff
Role of antimicrobial synergism in infected granulocytopenic patients.
European journal of cancer & clinical oncology 1984;20(8):1007-10.
1983: David E Johnson; Frank M Calia; M J Snyder; John W Warren; Stephen C Schimpff
Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats.
The Journal of antimicrobial chemotherapy 1983;12 Suppl D():89-96.
1981: David E Johnson; Frank M Calia
Hemolytic reaction of clinical and environmental strains of Vibrio vulnificus.
Journal of clinical microbiology 1981;14(4):457-9.
1976: David E Johnson; Frank M Calia
False-positive rabbit ileal loop reactions attributed to Vibrio parahaemolyticus broth filtrates.
The Journal of infectious diseases 1976;133(4):436-40.
1975: Frank M Calia; David E Johnson
Bacteremia in suckling rabbits after oral challenge with Vibrio parahaemolyticus.
Infection and immunity 1975;11(6):1222-5.